FDA Advisers Back Maternal RSV Vaccine As Pfizer Says Safety Concerns Can Be Studied Post-Approval
FDA Advisers Back Maternal RSV Vaccine As Pfizer Says Safety Concerns Can Be Studied Post-Approval Authored by Zachary Stieber via The Epoch Times (emphasis ours), Advisers to the U.S. Food…